

Author: Serafini Giuseppe Marineo Giuseppe Sabato Alessandro F.
Publisher: Maney Publishing
ISSN: 1568-5691
Source: The Pain Clinic, Vol.12, Iss.4, 2000-12, pp. : 287-298
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
This work aims to evaluate the use of a new electromedical device, conceived in an exclusive way to subvert the concept of electric nerve stimulation. It uses the nervous fiber as a passive means to convey, by means of a procedure that we might define as 'scrambling' (the technical meaning of scrambling is mixing of information), a message of normality to the CNS which should enable to recognize it as self and non-algic one, thus modifying the reflex adaptive responses. This technique has been named 'scrambler therapy'.According to the theoretical guidelines, we have conceived first a prototype and subsequently an electromedical device called Transcutaneous Electromanipulation by Nervous Patterns Scrambler (T.E.N.P.S.).Thirty-four patients, age 64±12, all affected by chronic neuropathic pain have been enrolled in this study. Among them, only 18 (13 M, 5 F) have followed the whole treatment protocol and the subsequent follow-up.Patients experiencing a pain reliefs ≥50% were considered responsive to the treatment. All data have been evaluated by means of statistical analysis tests (Student's t-test, variance) and elaborated by Xlstat software.The first results obtained using the explained device and protocol show an effectively significant VAS score reduction after each 'scrambler therapy' session. Moreover, mean pre-treatment VAS score graph shows a significant decreasing trend. This can be shown also by analyzing pain intensity difference (PID) and summatory PID (SPID) data. Only 16.7% of patients (3 subjects) were not responsive to this protocol, while 11.1% of them (2 patients) have experienced only partial pain-relief.
Related content


What is new in neuropathic pain?
By Davis Mellar
Supportive Care in Cancer, Vol. 15, Iss. 4, 2007-04 ,pp. :


Metformin: a new option in cancer treatment
Clinical and Translational Oncology, Vol. 13, Iss. 6, 2011-06 ,pp. :


Pathophysiological mechanisms of neuropathic pain
By Baron R.
The Pain Clinic, Vol. 12, Iss. 2, 2000-06 ,pp. :




By Fukui Sei Shigemori Shino Yamada Naoto Nosaka Shuichi
The Pain Clinic, Vol. 13, Iss. 4, 2002-01 ,pp. :